(Q36529889)

14 August 2017

1 reference

title

Employing tumor hypoxia for oncolytic therapy in breast cancer (English)

1 reference

14 August 2017

3

Yuman Fong

1 reference

14 August 2017

Yun Shin Chun

1

1 reference

14 August 2017

Prasad S Adusumilli

series ordinal

2

1 reference

14 August 2017

publication date

1 October 2005

1 reference

Journal of Mammary Gland Biology and Neoplasia

14 August 2017

published in

1 reference

14 August 2017

volume

10

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

311-318

1 reference

https://scigraph.springernature.com/pub.10.1007/s10911-006-9004-6

14 August 2017

exact match

0 references

cites work

A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-006-9004-6

Hypoxia reduces hormone responsiveness of human breast cancer cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10911-006-9004-6

Imaging hypoxia and angiogenesis in tumors

21 January 2018

1 reference

12 December 2020

HIF-1 as a target for drug development

1 reference

12 December 2020

1 reference

12 December 2020

Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone

1 reference

12 December 2020

Bioreductive drugs into the next millennium

1 reference

12 December 2020

The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

1 reference

12 December 2020

Targeting cancer with gene therapy using hypoxia as a stimulus

1 reference

12 December 2020

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

12 December 2020

Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.

1 reference

12 December 2020

Hypoxia-induced pathways in breast cancer

1 reference

12 December 2020

Development of a hypoxia-responsive vector for tumor-specific gene therapy

1 reference

12 December 2020

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

1 reference

12 December 2020

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

1 reference

12 December 2020

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

1 reference

12 December 2020

Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases

1 reference

12 December 2020

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

12 December 2020

The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors

1 reference

12 December 2020

Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).

1 reference

12 December 2020

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

12 December 2020

Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer

1 reference

12 December 2020

Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation

1 reference

12 December 2020

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

1 reference

12 December 2020

Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma

1 reference

12 December 2020

Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway

1 reference

12 December 2020

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

12 December 2020

The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma

1 reference

12 December 2020

Regression of Burkitt's lymphoma in association with measles infection.

1 reference

12 December 2020

Suppression of tumor growth through disruption of hypoxia-inducible transcription

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

1 reference

12 December 2020

Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

1 reference

12 December 2020

Targeting HIF-1 for cancer therapy

1 reference

12 December 2020

Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1

1 reference

12 December 2020

SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cells

1 reference

12 December 2020

Utilizing tumor hypoxia to enhance oncolytic viral therapy in colorectal metastases

1 reference

12 December 2020

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

12 December 2020

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.

1 reference

12 December 2020

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

12 December 2020

Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice

1 reference

12 December 2020

Conditionally replicating herpes vectors for cancer therapy

1 reference

12 December 2020

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

1 reference

12 December 2020

HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma

1 reference

12 December 2020

Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements

1 reference

12 December 2020

Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.

1 reference

12 December 2020

Tumor oxygenation correlates with molecular growth determinants in breast cancer

1 reference

12 December 2020

Treatment resistance of solid tumors: role of hypoxia and anemia

1 reference

12 December 2020

Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation

1 reference

12 December 2020

Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells

1 reference

12 December 2020

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

12 December 2020

Oncolytic herpes simplex virus vectors for the treatment of human breast cancer.

1 reference

12 December 2020

Regression of Hodgkin's disease after measles

1 reference

12 December 2020

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

1 reference

12 December 2020

Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors

1 reference

12 December 2020

Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene

1 reference

12 December 2020

Characterization of physiologically regulated vectors for the treatment of ischemic disease

1 reference

12 December 2020

Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen

1 reference

12 December 2020

Angiogenesis of breast cancer

1 reference

12 December 2020

Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer

1 reference

12 December 2020

Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer

1 reference

12 December 2020

Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival

1 reference

12 December 2020

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer

1 reference

12 December 2020

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

12 December 2020

10.1007/S10911-006-9004-6

Identifiers

DOI

1 reference

14 August 2017

1 reference